Education
About Us
Working with TipRanks
Follow Us
ProstaLund AB (SE:PLUN)
:PLUN
PLUN Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr0.91 - kr23.84
Previous CloseN/A
Volume452.00
Average Volume (3M)41.22K
Market Cap
kr3.59M
Enterprise Valuekr8.60B
Total Cash (Recent Filing)kr7.82M
Total Debt (Recent Filing)kr933.00K
Price to Earnings (P/E)―
Beta0.05
Next Earnings
Aug 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.39
Shares Outstanding3,624,052
10 Day Avg. Volume15,232
30 Day Avg. Volume41,221
Financial Highlights & Ratios
PEG Ratio-32.37
Price to Book (P/B)206.51
Price to Sales (P/S)0.00
P/FCF Ratio-410.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PLUN FAQ
What was ProstaLund AB’s price range in the past 12 months?
ProstaLund AB lowest stock price was kr0.91 and its highest was kr23.84 in the past 12 months.
What is ProstaLund AB’s market cap?
ProstaLund AB’s market cap is kr3.59M.
When is ProstaLund AB’s upcoming earnings report date?
ProstaLund AB’s upcoming earnings report date is Aug 21, 2025 which is in 62 days.
How were ProstaLund AB’s earnings last quarter?
ProstaLund AB released its earnings results on May 30, 2025. The company reported -kr1.39 earnings per share for the quarter, missing the consensus estimate of N/A by -kr1.39.
Is ProstaLund AB overvalued?
According to Wall Street analysts ProstaLund AB’s price is currently Overvalued.
Does ProstaLund AB pay dividends?
ProstaLund AB does not currently pay dividends.
What is ProstaLund AB’s EPS estimate?
ProstaLund AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ProstaLund AB have?
ProstaLund AB has 3,624,052 shares outstanding.
What happened to ProstaLund AB’s price movement after its last earnings report?
ProstaLund AB reported an EPS of -kr1.39 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 19.337%.
Which hedge fund is a major shareholder of ProstaLund AB?
Currently, no hedge funds are holding shares in SE:PLUN
Company Description
ProstaLund AB
ProstaLund AB is a Swedish medical technology company operating in the healthcare sector. The company specializes in developing and commercializing innovative products and solutions for minimally invasive treatment of benign prostatic hyperplasia (BPH). Its flagship product, the CoreTherm system, utilizes a proprietary technology for thermal treatment of BPH, offering patients an effective alternative to surgical procedures.
Technical Analysis
Active Biotech AB
―
Scandinavian ChemoTech AB Class B
―
LIDDS AB
―
Prostatype Genomics AB
―